Cantor Fitzgerald Estimates Cytokinetics FY2025 Earnings
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Investment analysts at Cantor Fitzgerald boosted their FY2025 EPS estimates for Cytokinetics in a research note issued to investors on Thursday, March 27th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will earn ($4.98) per share for the year, up from their prior estimate of […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Investment analysts at Cantor Fitzgerald boosted their FY2025 EPS estimates for Cytokinetics in a research note issued to investors on Thursday, March 27th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will earn ($4.98) per share for the year, up from their prior estimate of […]
